New patent for Bioxcel drug IGALMI

Igalmi, a drug marketed by Bioxcel and protected by eight patents, has dexmedetomidine hydrochloride as its generic ingredient. It is included in one new drug application (NDA) and available from a single supplier. The drug has 65 patent family members across sixteen countries.